2023
DOI: 10.1212/wnl.0000000000203515
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy and safety of different doses of subcutaneous galcanezumab in chronic and episodic migraine: A pooled analysis of 3651 patients (P10-12.003)

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles